307 related articles for article (PubMed ID: 8346171)
1. Diffuse alveolar damage and acute interstitial pneumonitis: histochemical evaluation with lectins and monoclonal antibodies against surfactant apoprotein and collagen type IV.
Sugiyama K; Kawai T
Mod Pathol; 1993 May; 6(3):242-8. PubMed ID: 8346171
[TBL] [Abstract][Full Text] [Related]
2. Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome.
Kang D; Nakayama T; Togashi M; Yamamoto M; Takahashi M; Kunugi S; Ishizaki M; Fukuda Y
Hum Pathol; 2009 Nov; 40(11):1618-27. PubMed ID: 19647854
[TBL] [Abstract][Full Text] [Related]
3. [Serum 7S collagen levels in diffuse interstitial lung diseases--an index of the destruction of alveolar structure].
Tamura A; Matsubara O; Akagawa S; Nagai H; Kurashima A; Yoshimura N; Ichioka M; Kasuga T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30(12):2089-97. PubMed ID: 1289629
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of human pulmonary surfactant apoproteins with monoclonal antibodies. Pathologic application for hyaline membrane disease.
Kuroki Y; Dempo K; Akino T
Am J Pathol; 1986 Jul; 124(1):25-33. PubMed ID: 3524252
[TBL] [Abstract][Full Text] [Related]
5. Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS).
Mukhopadhyay S; Parambil JG
Semin Respir Crit Care Med; 2012 Oct; 33(5):476-85. PubMed ID: 23001802
[TBL] [Abstract][Full Text] [Related]
6. The potential role of BAX and BCL-2 expression in diffuse alveolar damage.
Guinee D; Brambilla E; Fleming M; Hayashi T; Rahn M; Koss M; Ferrans V; Travis W
Am J Pathol; 1997 Oct; 151(4):999-1007. PubMed ID: 9327733
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical localization of surfactant apoproteins in usual interstitial pneumonia associated with pulmonary carcinoma.
Chung JH; Kitaichi M; Ham EK; Seo JW
Microsc Res Tech; 1998 Aug; 42(3):234-8. PubMed ID: 9764924
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
Hayashi T; Stetler-Stevenson WG; Fleming MV; Fishback N; Koss MN; Liotta LA; Ferrans VJ; Travis WD
Am J Pathol; 1996 Oct; 149(4):1241-56. PubMed ID: 8863673
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of ubiquitin-positive intracytoplasmic eosinophilic inclusion bodies in diffuse alveolar damage.
Yamada T; Uehara K; Kawanishi R; Mizutani T; Sunagawa K; Araya J; Kawabata Y
Histopathology; 2006 Jun; 48(7):846-54. PubMed ID: 16722934
[TBL] [Abstract][Full Text] [Related]
10. Alveolar basement membrane breaks down in diffuse alveolar damage: an immunohistochemical study.
Matsubara O; Tamura A; Ohdama S; Mark EJ
Pathol Int; 1995 Jul; 45(7):473-82. PubMed ID: 7551006
[TBL] [Abstract][Full Text] [Related]
11. Histochemical reactivities of lectins and surfactant apoprotein in pulmonary adenocarcinomas and their metastases.
Sugiyama K; Kawai T; Nakanishi K; Suzuki M
Mod Pathol; 1992 May; 5(3):273-6. PubMed ID: 1495933
[TBL] [Abstract][Full Text] [Related]
12. Presence of apocrine epithelial antigen (AEA) in type II pneumocytes and in hyaline membranes of neonatal RDS.
Forsman LM; Hallman M; Autero M; Rapola J; Andersson LC
J Pathol; 1986 Dec; 150(4):289-94. PubMed ID: 3806285
[TBL] [Abstract][Full Text] [Related]
13. The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage.
Fukuda Y; Ishizaki M; Masuda Y; Kimura G; Kawanami O; Masugi Y
Am J Pathol; 1987 Jan; 126(1):171-82. PubMed ID: 3812636
[TBL] [Abstract][Full Text] [Related]
14. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.
Churg A; Müller NL; Silva CI; Wright JL
Am J Surg Pathol; 2007 Feb; 31(2):277-84. PubMed ID: 17255773
[TBL] [Abstract][Full Text] [Related]
15. Organizing pneumonia and pulmonary lymphatic architecture in diffuse alveolar damage.
Mandal RV; Mark EJ; Kradin RL
Hum Pathol; 2008 Aug; 39(8):1234-8. PubMed ID: 18602671
[TBL] [Abstract][Full Text] [Related]
16. Patterns of pulmonary structural remodeling after experimental paraquat toxicity. The morphogenesis of intraalveolar fibrosis.
Fukuda Y; Ferrans VJ; Schoenberger CI; Rennard SI; Crystal RG
Am J Pathol; 1985 Mar; 118(3):452-75. PubMed ID: 3883797
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis is a major pathway responsible for the resolution of type II pneumocytes in acute lung injury.
Bardales RH; Xie SS; Schaefer RF; Hsu SM
Am J Pathol; 1996 Sep; 149(3):845-52. PubMed ID: 8780388
[TBL] [Abstract][Full Text] [Related]
18. Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage.
Guinee D; Fleming M; Hayashi T; Woodward M; Zhang J; Walls J; Koss M; Ferrans V; Travis W
Am J Pathol; 1996 Aug; 149(2):531-8. PubMed ID: 8701992
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of immunohistochemically detected surfactant--apoprotein-A in malignant tumors located in the lungs: report of two cases.
Goldmann T; Galle J; Wiedorn KH; Deutschbein ME; Neuhaus M; Branscheid D; Vollmer E
Ann Diagn Pathol; 2001 Apr; 5(2):84-90. PubMed ID: 11294993
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary corpora amylacea contain surfactant apoprotein.
Akino T; Mizumoto M; Shimizu H; Kuroki Y; Dempo K; Tsuda T; Yanai S; Mizuki M
Pathol Res Pract; 1990 Oct; 186(5):687-91; discussion 691-5. PubMed ID: 2287594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
